Impact of Therapeutic Inertia on Patient-Reported Outcomes in Moderate-to-Severe Atopic Dermatitis: A 12-Month Longitudinal Study from the TARGET-DERM AD Registry. J of Skin 2024, 8 (6), s463. https://doi.org/10.25251/skin.8.supp.463.